Quaker Houghton (KWR)
(Delayed Data from NYSE)
$161.60 USD
+1.57 (0.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $161.47 -0.13 (-0.08%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$161.60 USD
+1.57 (0.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $161.47 -0.13 (-0.08%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
Zacks News
4 Best Specialty Chemical Stocks to Buy for 2019
by Tirthankar Chakraborty
A strong export market and rise in business investment spending have boosted demand in end-use markets for the U.S. chemical industry.
VALE to Benefit From Increasing Demand Amid Cost Concerns
by Zacks Equity Research
Vale (VALE) is poised to gain from rising demand, investment in projects and lower debt despite elevated costs.
Here's Why You Should Hold Onto Celanese (CE) Stock Now
by Anindya Barman
Celanese's (CE) strategic measures including cost savings through productivity actions and acquisitions are expected to drive its earnings.
Should You Get Rid of International Flavors (IFF) Stock Now?
by Zacks Equity Research
High input costs, supply chain challenges and high debt levels are weighing down International Flavors & Fragrances (IFF) currently.
Chemicals Witness a Soft Q4 With Sluggish Production Growth
by Anindya Barman
The prospects of the chemical industry have been clouded by the U.S.-China trade friction.
Nucor (NUE) to Build $1.35B Steel Plate Mill in U.S. Midwest
by Anindya Barman
The new mill will strengthen Nucor's (NUE) ability to serve customers in the Midwest and boost its position in steel plate products.
Here's Why You Should Buy Mosaic (MOS) Stock Right Now
by Anindya Barman
Let's see what makes Mosaic (MOS) stock an attractive investment option at the moment.
Why Should You Hold Onto Eastman Chemical Stock for Now?
by Anindya Barman
Eastman Chemical (EMN) is gaining from growth of its high-margin specialty products and cost management actions.
Here's Why You Should Hold Onto Reliance Steel (RS) Stock Now
by Anindya Barman
Reliance Steel & Aluminum Co. (RS) is gaining from favorable metal pricing and strong demand.
Here's Why Century Aluminum (CENX) is Worth Buying Right Now
by Anindya Barman
Let's see what makes Century Aluminum (CENX) stock an attractive investment option at the moment.
Ingevity's (NGVT) Shares Rise 15% in a Year: Here's Why
by Anindya Barman
Let's take a look into the factors that are driving Ingevity (NGVT).
DQ vs. KWR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DQ vs. KWR: Which Stock Is the Better Value Option?
DQ vs. KWR: Which Stock Is the Better Value Option?
by Zacks Equity Research
DQ vs. KWR: Which Stock Is the Better Value Option?
Quaker Chemical (KWR) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 3.90% and 0.30%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Quaker Chemical (KWR) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quaker Chemical (KWR) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
International Paper at a 52-Week Low: What's Taking It Down?
by Zacks Equity Research
Elevated costs and adverse foreign currency translation will likely hurt International Paper's (IP) share-price performance in the near term.
5 Chemical Stocks That Are Poised for Solid Upside in Q4
by Anindya Barman
As the chemical industry's upturn is likely to continue in Q4, it would be prudent to zero in on these chemical stocks that have compelling prospects.
International Flavors & Fragrances Completes Frutarom Buy
by Zacks Equity Research
Following the completion of the Frutarom acquisition, International Flavors & Fragrances, Inc. (IFF) now boasts a differentiated portfolio and an expanded customer base.
Why Should You Add Celanese (CE) to Your Portfolio Now?
by Anindya Barman
Strong fundamentals and compelling growth prospects make Celanese (CE) an attractive choice for investment.
5 Reasons to Add Eastman Chemical (EMN) to Your Portfolio
by Anindya Barman
Based on its compelling prospects, we believe Eastman Chemical (EMN) has plenty of upside potential.
Vale (VALE) Scales 52-Week High: What's Driving the Rally?
by Zacks Equity Research
Rise in global steel production, demand for higher iron ore grade and increased liquidity is likely to strengthen Vale SA's (VALE) competency, going forward.
5 Reasons to Add Cabot (CBT) Stock to Your Portfolio Now
by Anindya Barman
Based on its compelling prospects, we believe Cabot (CBT) has plenty of upside potential.
Reasons Why You Should Hold Domtar (UFS) Stock Right Now
by Zacks Equity Research
Domtar's (UFS) results will be driven by improvement in paper shipments, despite freight cost inflation and adverse foreign currency-translation impact.
Praxair (PX) Scales 52-Week High: What's Driving the Rally?
by Zacks Equity Research
Anticipated merger with Linde, solid backlog and new order wins will likely drive Praxair's (PX) share-price performance in the near term.